| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana;
Eli Lilly Canada, Toronto, Ontario, Canada; and
University of Toronto, Toronto, Ontario, Canada
Correspondence: Address reprint requests to Michael R. DeFelippis, Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Drop Code 3844, Indianapolis, IN 46285. Tel.: 317-276-6027; Fax: 317-277-0833; E-mail: defelippis_michael_r{at}lilly.com.
Glucagon solutions at pH 2.0 were subjected to mechanical agitation at 37°C in the presence of a hydrophobic surface to explore the details of aggregation and fiber formation. High-resolution intermittent-contact atomic force microscopy performed in solution revealed the presence of aggregates after 0.5 h; however, longer agitation times resulted in the formation of fibrillated structures with varying levels of higher-order assembly. Height, periodicity, and amplitude measurements of these structures allowed the identification of four distinct fiber types. The most elementary fiber form, designated a filament, self-associates in a specific wound fashion to produce protofibrils composed of two filaments. Subsequent self-assembly of these filaments and protofibrils leads to two well-defined fibrillar motifs, termed Type I and Type II. Atomic force microscopy imaging of pH 2.8 glucagon solutions not agitated or exposed to elevated temperature revealed the presence of amorphous aggregates before the formation of fibrillar structures similar to those seen at pH 2.0. Time-course solution Fourier transform infrared spectroscopy and thioflavin T binding studies suggested that glucagon aggregation and fibril formation were associated with the development of ß-sheet structure. The results of these studies are used to describe a possible mechanism for glucagon aggregation and fibrillation that is consistent with a hierarchical assembly model proposed for amyloid fibril formation.
This article has been cited by other articles:
![]() |
M. E. van Raaij, J. van Gestel, I. M. J. Segers-Nolten, S. W. de Leeuw, and V. Subramaniam Concentration Dependence of {alpha}-Synuclein Fibril Length Assessed by Quantitative Atomic Force Microscopy and Statistical-Mechanical Theory Biophys. J., November 15, 2008; 95(10): 4871 - 4878. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Herczenik and M. F. B. G. Gebbink Molecular and cellular aspects of protein misfolding and disease FASEB J, July 1, 2008; 22(7): 2115 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. P. Svane, K. Jahn, T. Deva, A. Malmendal, D. E. Otzen, J. Dittmer, and N. Chr. Nielsen Early Stages of Amyloid Fibril Formation Studied by Liquid-State NMR: The Peptide Hormone Glucagon Biophys. J., July 1, 2008; 95(1): 366 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Hovgaard, M. Dong, D. E. Otzen, and F. Besenbacher Quartz Crystal Microbalance Studies of Multilayer Glucagon Fibrillation at the Solid-Liquid Interface Biophys. J., September 15, 2007; 93(6): 2162 - 2169. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |